Doctor Bach Thi Chinh, Medical Director, VNVC Vaccination System, said that the MenACWY-TT vaccine is produced by the world's leading pharmaceutical group Pfizer (USA) at a modern factory in Belgium. The vaccine applies advanced synthetic technology, combined with protein from Tetetanus Toxoid (TT) to help "train" the immune system to identify and destroy scoliosis bacteria, create sustainable antibodies, maintain long-term immune memory and reduce the rate of healthy people withparasite.
This is the world's first quadriplegic vaccine in the world, prescribed for children from 6 weeks to adults. To date, the vaccine has been used safely in more than 80 countries with over 32 million doses. Vietnam is one of the few countries in Southeast Asia that is prioritized for this important vaccine supply.
VNVC's pioneering use of the MenACWY-TT vaccine not only opens up opportunities for Vietnamese children to be protected early in their first weeks, but also affirms their determination to integrate, quickly access advanced medical achievements and catch up with global infectious disease prevention trends.
On the morning of August 15, hearing that VNVC had a newly developed vaccine for meningococcal, Ms. Vu Thi Thanh, 40 years old (Vinh Loc commune, Ho Chi Minh City) gave her 4-year-old son a shot. She shared: I learned that globular brain causing meningitis is very dangerous, and the hot season can easily cause children's health to decline. My child is in preschool, the environment is crowded so he is susceptible to infection. This new cellulose vaccine prevents dangerous strains and maintains the long-term immune system, I took my child for vaccination to prevent the disease before he entered the new school year, Ms. Thanh shared.
According to Dr. Chinh, the globular brain is also known as a "24-hour disease" because it can take the life of a healthy person in less than 24 hours, in which the individual can have a severe sepsis that can cause death within just 6-8 hours. In Vietnam, meningococcal disease is classified as a group of 6 leading dangerous infectious diseases with the highest mortality rate. Since the beginning of the year alone, our country has recorded dozens of cases, at least 2 deaths, warning of the risk of an outbreak in the Southern region.
Children under 12 months old are at risk of disease and have the highest sequelae due to brain tissue. Meanwhile, the disease is difficult to recognize early. In young children, in the first 8 hours from the start, they often only have vague symptoms such as mild fever, crying, sucking, sore throat or runny nose, easily confused with common cold, flu or respiratory infections. When typical signs such as suddenness of bleeding, stiff neck, and fear of light appear, the disease has progressed severely, making treatment difficult and the risk of death high. If not treated promptly, up to 50% of patients will die.
10-20% of those who are lucky enough to survive will suffer from severe sequelae such as limbs, scars, hearing loss, blindness, kidney failure, heart failure, seizures, seizures, and behavioral disorders. The rate of sequelae can be up to 50% in children under 12 months old. Scalp tissue bacteria can reside silently in the throat for several days to several months without causing symptoms, becoming an uncontrollable source of spread.
Having an early-proofing scoliosis vaccine for children from 6 weeks old helps fill the immune gap when the mother's antibodies are gradually decreasing, while protecting children at the right time to start interacting with the community, reducing the risk of spreading and boosting immunity to the surrounding community, Dr. Chinh shared.
Doctor Chinh noted that globular vaccines do not have cross-immunity, so children and adults should be vaccinated with vaccines of group B and group A, C, Y, W to fully prevent all 5 serotypes that cause the disease. Depending on vaccination history, epidemic situation, age and needs, etc., the doctor will prescribe the appropriate vaccine and vaccination schedule to achieve the most optimal protection effect.
Along with the MenACWY-TT vaccine, VNVC has become the first vaccination system in Vietnam to provide a complete set of 5 vaccines for globular vaccine prevention, comprehensive protection against 5 serotypes A, B, C, Y, W-135 for all ages, from children, adolescents to adults and the elderly.
Thus, since the beginning of 2025, VNVC has continuously brought to Vietnam many new-generation vaccines, such as the ACYW brain-crushed vaccine for children from 12 months old, wholesalers 15 and 20, affirming its pioneering role in quickly bringing advanced medical achievements to the people.
